2016 CMO Leadership Award Won by Dalton Pharma Services

Share Article

Dalton Pharma Services, a leading pharmaceutical cGMP contract manufacturing company, announced today that it has been selected by its clients to receive a 2016 CMO Leadership Award in all five core categories in the competition: Quality, Reliability, Capabilities, Expertise and Compatibility.

30 years

I am pleased to be part of a talented group of scientists that has been able to manage and deliver technically challenging pharmaceutical projects within a highly regulated framework, commented Karina Lahnakoski, Director of Quality

Dalton Pharma Services, a leading pharmaceutical cGMP contract manufacturing company, announced today that it has been selected by its clients to receive a 2016 CMO Leadership Award in all five core categories in the competition: Quality, Reliability, Capabilities, Expertise and Compatibility.

For the 2016 CMO Leadership Awards, Life Science Leader magazine teamed up with Industry Standard Research (ISR) to determine the award recipients. Dalton was one of 83 contract manufacturers assessed by 26 performance metrics. Respondents only evaluated companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensured that quality ratings came from actual involvement with a business and that companies identified as leaders were backed by experiential data.

Dalton is honoured to receive an award for each of the following categories:

  • Quality (Overall*) and Quality (Small Pharma)
  • Reliability (Overall*) and Reliability (Small Pharma)
  • Capabilities (Overall*) and Capabilities (Small Pharma)
  • Expertise (Overall*) and Expertise (Small Pharma)
  • Compatibility (Overall*) and Compatibility (Small Pharma)

*Overall = combined Big Pharma and Small Pharma

“This award is especially satisfying after 30 years supporting our clients with comprehensive drug discovery, development and manufacturing services. Dalton’s employees support our clients' programs in some of the most technically challenging areas of science”, said Peter Pekos, CEO and President, Dalton Pharma Services. “This award recognizes Dalton’s management team’s success in building a culture of excellence bringing innovation to our clients' drug development programs. Leading investors, Pharma companies and their management teams have validated our effort and dedication to their success through The CMO Leadership Award.”

"I am pleased to be part of a talented group of scientists that has been able to manage and deliver technically challenging pharmaceutical projects within a highly regulated framework", commented Karina Lahnakoski, Director of Quality, Dalton Pharma Services. “

About Dalton:
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a leading cGMP contract service provider of integrated chemistry, drug development and dosage form manufacturing services to the pharmaceutical and biotechnology industries. Dalton provides expertise in medicinal chemistry, process development and reaction optimization, as well as formulation development, analytical testing and development, and cGMP manufacturing including cGMP API production and cGMP Sterile Filling Services including Sterile Powder Filling.

A wide range of GMP small molecule APIs is manufactured for its global customer base on a contract basis. The Company conducts cGMP manufacturing of API's from bench top to multi-kilo scales in its API suites rated at Class 10,000 (Class C). Its upgraded cGMP manufacturing areas can support reactor sizes up to 300L. Dalton brings nearly 30 years of experience to every customer project, at virtually any stage of development or commercialization. For more information, please visit: http://www.dalton.com

For further information contact:
Peter Pekos
President & CEO
Dalton Pharma Services
349 Wildcat Road
Toronto, Ontario
Tel: 416-661-2102
ppekos(at)dalton(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Peter Pekos
Visit website